|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 98.50 SAR | -1.30% |
|
-1.79% | -16.24% |
| 11-18 | Kepler Cheuvreux Reduces Nahdi Medical's PT, Affirms Buy Rating | MT |
| 11-03 | HSBC Trims Nahdi Medical PT, Affirms Buy Rating | MT |
| Capitalization | 12.8B 3.41B 2.91B 2.71B 2.55B 4.7B 309B 5.13B 31.59B 12.27B 146B 12.53B 531B | P/E ratio 2025 * |
15.7x | P/E ratio 2026 * | 14.5x |
|---|---|---|---|---|---|
| Enterprise value | 14.12B 3.76B 3.21B 2.99B 2.82B 5.18B 341B 5.66B 34.84B 13.53B 161B 13.82B 586B | EV / Sales 2025 * |
1.4x | EV / Sales 2026 * | 1.24x |
| Free-Float |
36.92% | Yield 2025 * |
5.54% | Yield 2026 * | 5.8% |
| 1 day | -1.30% | ||
| 1 week | -1.79% | ||
| Current month | -0.66% | ||
| 1 month | -8.80% | ||
| 3 months | -11.74% | ||
| 6 months | -22.32% | ||
| Current year | -16.24% |
| 1 week | 97.85 |  | 102.9 |
| 1 month | 95.6 | | 109.9 |
| Current year | 95.6 | | 132.1 |
| 1 year | 95.6 | | 132.1 |
| 3 years | 95.6 | | 190.4 |
| 5 years | 95.6 | | 209.4 |
| 10 years | 95.6 | | 209.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yasser Joharji
CEO | Chief Executive Officer | 54 | 31/12/2013 |
| Director of Finance/CFO | 51 | - | |
Khalid Tadlaoui
CTO | Chief Tech/Sci/R&D Officer | 58 | 31/12/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 74 | 31/12/2020 | |
| Director/Board Member | 63 | 17/06/1986 | |
| Director/Board Member | 72 | 31/12/2020 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 0.02% | 51 M€ | +4.72% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.30% | -1.79% | -18.46% | -38.36% | 3.41B | |
| +3.46% | -0.75% | +95.58% | -25.78% | 24.57B | |
| +4.31% | -2.02% | +41.38% | -41.81% | 11.07B | |
| +1.07% | +1.31% | +28.28% | +37.93% | 7.33B | |
| -0.01% | -2.83% | -15.49% | +16.50% | 4.65B | |
| -0.89% | -4.29% | -11.36% | -44.28% | 3.84B | |
| +3.73% | +1.82% | -9.33% | +75.61% | 2.94B | |
| +0.41% | -3.14% | +4.73% | -54.47% | 2.79B | |
| -3.18% | +1.41% | +19.90% | - | 1.91B | |
| -0.96% | -0.26% | -5.20% | +14.90% | 1.78B | |
| Average | +0.66% | -0.57% | +13.00% | -6.64% | 6.43B | |
| Weighted average by Cap. | +2.13% | -0.78% | +44.33% | -15.15% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 10.11B 2.7B 2.3B 2.14B 2.02B 3.71B 244B 4.05B 24.95B 9.69B 115B 9.9B 420B | 11.15B 2.97B 2.53B 2.36B 2.22B 4.09B 269B 4.47B 27.51B 10.68B 127B 10.92B 463B |
| Net income | 815M 217M 185M 173M 163M 299M 19.66B 326M 2.01B 781M 9.27B 798M 33.82B | 885M 236M 201M 188M 177M 325M 21.36B 355M 2.18B 848M 10.07B 867M 36.75B |
| Net Debt | 1.32B 351M 299M 279M 263M 483M 31.79B 528M 3.25B 1.26B 14.99B 1.29B 54.68B | 1.07B 286M 244M 228M 214M 394M 25.9B 430M 2.65B 1.03B 12.21B 1.05B 44.56B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/12/25 | 98.50 ﷼ | -1.30% | 366,697 |
| 10/12/25 | 99.80 ﷼ | +0.50% | 128,299 |
| 09/12/25 | 99.30 ﷼ | -0.45% | 238,304 |
| 08/12/25 | 99.75 ﷼ | -3.06% | 204,126 |
| 07/12/25 | 102.90 ﷼ | +2.59% | 151,565 |
Delayed Quote Saudi Arabian S.E., December 11, 2025 at 12:20 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4164 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition